PBE

Invesco Biotechnology & Genome ETF

PBE | AMEX
$102.33
-$1.13 (-1.09%)
At close: Oct 30, 2026, 3:59 PM ET
$102.38
+$0.05 (+0.05%)
After-hours: Oct 30, 2026, 3:28 PM ET
-1.09%

No price chart data available for 1D timeframe.

Key Statistics

Market Cap 311.99M
AVG Volume 6.75K
AUM 286.25M
NAV 91.16
1D Range
101.92 104.58
52W Range
73.76 104.58

About PBE

The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to ...

Asset Class Equity
Holdings 31
Inception Date Jun 23, 2005
Expense Ratio 0.58%
Domicile United States
ISIN US46137V7872
Provider Invesco

Top Sectors

Sector Weight
Healthcare 99.96%
Financial Services 0.04%

Top Holdings

23.77% of assets
Name Symbol Weight
Vertex Pharmaceutica... VRTX 4.97%
Amgen Inc AMGN 4.83%
Royalty Pharma PLC RPRX 4.68%
Regeneron Pharmaceut... REGN 4.68%
Biogen Inc BIIB 4.61%

Dividends

Yield 1.3%
Ex-Div Amount Pay Date
Sep 21, 26 $0.0187 Sep 25, 26
Jun 22, 26 $0.8106 Jun 26, 26
Mar 23, 26 $0.0824 Mar 27, 26
Dec 22, 25 $0.4197 Dec 26, 25
Sep 22, 25 $0.2341 Sep 26, 25

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.